Birdwatch Note Rating
2023-03-16 00:12:10 UTC - HELPFUL
Rated by Participant: FDE4C5F5B12C09236F809D4AF2BD9908282C5DBCAA9D42A73A63C5EBD801302E
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details